Drugs Health Pharma

Akero Therapeutics says mid-stage trials on drug for fatty liver disease positive

HQ Team March 4, 2024: US-based Akero Therapeutics, Inc., announced its mid-trial of a drug to treat fatty liver disease met its primary.

Read More
Drugs Medical Pharma

Gilead buys CymaBay for $ 4.3b to expand its liver portfolio

HQ Team February 13, 2024: Gilead Sciences is buying CymaBay Therapeutics for $4.3 billion, to access its portfolio of drugs for liver and.

Read More
Drugs Health Pharma

Egypt close to ending hepatitis C, gets WHO ‘gold tier’ status

HQ Team October 9, 2023: Egypt has been granted a “gold tier” status by the WHO for providing 93% of those diagnosed with.

Read More
Drugs Health Pharma

FDA applies brakes on Merck’s multiple sclerosis drug tests

HQ Team April 13, 2023: Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its.

Read More
Drugs Health Pharma

Cure for nonalcoholic fatty liver disease may be near: Scientists say

HQ Team April 11, 2023: Scientists are close to developing a human treatment for nonalcoholic fatty liver after successfully developing a compound tested.

Read More
X